Pfizer walks away from AstraZeneca deal
May 26, 2014 at 10:41 AM EDT
Pfizer Inc. walks away from its offer to purchase AstraZeneca for $120 billion, putting an end to a month-long pursuit.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.